Ubidecarenone(BPGbio)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameUbidecarenone(BPGbio)
Drug Alias NameBPM31510-IVBPM31510-TBPM31510-OralAPI-31510BP31510 +[6
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoenzyme Q10 DeficiencySolid tumoursPoisoning +[11
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBPGbio Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesBerg Llc
Active IndicationsCoenzyme Q10 DeficiencyPoisoningEpidermolysis Bullosa +[6
Inactive IndicationsSolid tumoursNeoplasm MetastasisPancreatic Neoplasms +[5

Other Information

ATC CodeN/A
Related LinksN/A